Molecular Templates, Inc. engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. It utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. The company was founded by Eric E. Poma, Jean Gariépy, and Leigh Revers in 2001 and is headquartered in Austin, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Molecular Templates Inc market cap is $658.00.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Molecular Templates Inc 52 week high is $1.59 as of November 22, 2026.
Molecular Templates Inc stock price today is $0.0001.
Molecular Templates Inc stock price yesterday was $0.0001.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Molecular Templates Inc P/B ratio is 0.0001.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Molecular Templates Inc 50-day moving average is $0.0007.